spacer
spacer
Go to PDB code: 
protein metals Protein-protein interface(s) links
Transferase PDB id
1l9m
Jmol
Contents
Protein chains
675 a.a. *
Metals
_CA ×2
_BR ×2
_CL ×2
Waters ×901
* Residue conservation analysis
PDB id:
1l9m
Name: Transferase
Title: Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions change structure for activation
Structure: Protein-glutamine glutamyltransferase e3. Chain: a, b. Synonym: transglutaminase 3, tgm3, tgase e3. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Tissue: foreskin. Gene: tgm3. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9. Pvl1392 (invitrogen).
Resolution:
2.10Å     R-factor:   0.182     R-free:   0.225
Authors: B.Ahvazi
Key ref:
B.Ahvazi et al. (2002). Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation. EMBO J, 21, 2055-2067. PubMed id: 11980702 DOI: 10.1093/emboj/21.9.2055
Date:
26-Mar-02     Release date:   29-May-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q08188  (TGM3_HUMAN) -  Protein-glutamine gamma-glutamyltransferase E
Seq:
Struc:
 
Seq:
Struc:
693 a.a.
675 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 4 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.2.3.2.13  - Protein-glutamine gamma-glutamyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Protein glutamine + alkylamine = protein N5-alkylglutamine + NH3
Protein glutamine
+ alkylamine
= protein N(5)-alkylglutamine
+ NH(3)
      Cofactor: Calcium
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     cytoplasm   2 terms 
  Biological process     cell envelope organization   8 terms 
  Biochemical function     catalytic activity     10 terms  

 

 
    reference    
 
 
DOI no: 10.1093/emboj/21.9.2055 EMBO J 21:2055-2067 (2002)
PubMed id: 11980702  
 
 
Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.
B.Ahvazi, H.C.Kim, S.H.Kee, Z.Nemes, P.M.Steinert.
 
  ABSTRACT  
 
Transglutaminase (TGase) enzymes catalyze the formation of covalent cross-links between protein-bound glutamines and lysines in a calcium-dependent manner, but the role of Ca(2+) ions remains unclear. The TGase 3 isoform is widely expressed and is important for epithelial barrier formation. It is a zymogen, requiring proteolysis for activity. We have solved the three-dimensional structures of the zymogen and the activated forms at 2.2 and 2.1 A resolution, respectively, and examined the role of Ca(2+) ions. The zymogen binds one ion tightly that cannot be exchanged. Upon proteolysis, the enzyme exothermally acquires two more Ca(2+) ions that activate the enzyme, are exchangeable and are functionally replaceable by other lanthanide trivalent cations. Binding of a Ca(2+) ion at one of these sites opens a channel which exposes the key Trp236 and Trp327 residues that control substrate access to the active site. Together, these biochemical and structural data reveal for the first time in a TGase enzyme that Ca(2+) ions induce structural changes which at least in part dictate activity and, moreover, may confer substrate specificity.
 
  Selected figure(s)  
 
Figure 5.
Figure 5 Structural comparison of the zymogen and activated form. The upper and lower rows represent images rotated 180° with respect to each other, to show the channel in the active form. The electrostatic surface potential maps are shown in the center. The acidic and basic regions are colored red and blue, respectively. The arrow denotes a channel that opens on binding of a Ca^2+ ion in site 3. On the left and right are secondary structure images of the zymogen and the activated TGase 3 in the same orientations. The electrostatic potential, including calcium ions, has been mapped onto the surface plan from -15.0 kT (deep red) to +15.0 kT (deep blue).
Figure 6.
Figure 6 Stereo view images of the novel channel opened by Ca^2+ ion binding in site 3. Protein domains are colored as in Figure 3. (A) On one side, the electrostatic surface potential (black transparent) shows that the active site triad residues Cys272, His330 and Asp353 are buried and inaccessible. The movement of the loop bearing residues Asp320−Ser325 opens the channel in the activated TGase 3, and exposes the side chains of the Trp236 and Trp327 residues. (B) On the opposite side, the guanidinium group of Arg396 has moved to form a salt bridge with Glu586, allowing the hole to extend through the protein.
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: EMBO J (2002, 21, 2055-2067) copyright 2002.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20880254 I.Komáromi, Z.Bagoly, and L.Muszbek (2011).
Factor XIII: novel structural and functional aspects.
  J Thromb Haemost, 9, 9.  
20033238 C.M.Bergamini, A.Dondi, V.Lanzara, M.Squerzanti, C.Cervellati, K.Montin, C.Mischiati, G.Tasco, R.Collighan, M.Griffin, and R.Casadio (2010).
Thermodynamics of binding of regulatory ligands to tissue transglutaminase.
  Amino Acids, 39, 297-304.  
19262604 P.L.Zeeuwen, T.Cheng, and J.Schalkwijk (2009).
The biology of cystatin M/E and its cognate target proteases.
  J Invest Dermatol, 129, 1327-1338.  
19640581 T.A.Spurlin, K.Bhadriraju, K.H.Chung, A.Tona, and A.L.Plant (2009).
The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling.
  Biomaterials, 30, 5486-5496.  
19438477 T.Cheng, G.S.Tjabringa, I.M.van Vlijmen-Willems, K.Hitomi, P.E.van Erp, J.Schalkwijk, and P.L.Zeeuwen (2009).
The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis.
  Br J Dermatol, 161, 253-264.  
19005484 T.Cheng, I.M.van Vlijmen-Willems, K.Hitomi, M.C.Pasch, P.E.van Erp, J.Schalkwijk, and P.L.Zeeuwen (2009).
Colocalization of cystatin M/E and its target proteases suggests a role in terminal differentiation of human hair follicle and nail.
  J Invest Dermatol, 129, 1232-1242.  
20161049 T.M.Jeitner, N.A.Muma, K.P.Battaile, and A.J.Cooper (2009).
Transglutaminase activation in neurodegenerative diseases.
  Future Neurol, 4, 449-467.  
17762858 R.Jans, M.T.Sturniolo, and R.L.Eckert (2008).
Localization of the TIG3 transglutaminase interaction domain and demonstration that the amino-terminal region is required for TIG3 function as a keratinocyte differentiation regulator.
  J Invest Dermatol, 128, 517-529.  
17024410 K.M.Boeshans, T.C.Mueser, and B.Ahvazi (2007).
A three-dimensional model of the human transglutaminase 1: insights into the understanding of lamellar ichthyosis.
  J Mol Model, 13, 233-246.  
16689864 B.Méhul, D.Bernard, M.Brouard, C.Delattre, and R.Schmidt (2006).
Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis.
  Exp Dermatol, 15, 469-477.  
17179049 G.E.Begg, L.Carrington, P.H.Stokes, J.M.Matthews, M.A.Wouters, A.Husain, L.Lorand, S.E.Iismaa, and R.M.Graham (2006).
Mechanism of allosteric regulation of transglutaminase 2 by GTP.
  Proc Natl Acad Sci U S A, 103, 19683-19688.  
17073438 S.Datta, M.A.Antonyak, and R.A.Cerione (2006).
Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.
  Biochemistry, 45, 13163-13174.  
16565075 T.Cheng, K.Hitomi, I.M.van Vlijmen-Willems, G.J.de Jongh, K.Yamamoto, K.Nishi, C.Watts, T.Reinheckel, J.Schalkwijk, and P.L.Zeeuwen (2006).
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
  J Biol Chem, 281, 15893-15899.  
15740639 J.Zhang, H.Y.Zhi, F.Ding, A.P.Luo, and Z.H.Liu (2005).
Transglutaminase 3 expression in C57BL/6J mouse embryo epidermis and the correlation with its differentiation.
  Cell Res, 15, 105-110.  
15846304 M.T.Sturniolo, R.A.Chandraratna, and R.L.Eckert (2005).
A novel transglutaminase activator forms a complex with type 1 transglutaminase.
  Oncogene, 24, 2963-2972.  
15737187 R.L.Eckert, M.T.Sturniolo, A.M.Broome, M.Ruse, and E.A.Rorke (2005).
Transglutaminase function in epidermis.
  J Invest Dermatol, 124, 481-492.  
15084592 B.Ahvazi, K.M.Boeshans, and P.M.Steinert (2004).
Crystal structure of transglutaminase 3 in complex with GMP: structural basis for nucleotide specificity.
  J Biol Chem, 279, 26716-26725.
PDB code: 1sgx
14645372 B.Ahvazi, K.M.Boeshans, W.Idler, U.Baxa, P.M.Steinert, and F.Rastinejad (2004).
Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium.
  J Biol Chem, 279, 7180-7192.
PDB codes: 1rle 1rll 1vjj
15247907 K.Arita, H.Hashimoto, T.Shimizu, K.Nakashima, M.Yamada, and M.Sato (2004).
Structural basis for Ca(2+)-induced activation of human PAD4.
  Nat Struct Mol Biol, 11, 777-783.
PDB codes: 1wd8 1wd9 1wda
15010546 R.A.Chica, P.Gagnon, J.W.Keillor, and J.N.Pelletier (2004).
Tissue transglutaminase acylation: Proposed role of conserved active site Tyr and Trp residues revealed by molecular modeling of peptide substrate binding.
  Protein Sci, 13, 979-991.  
12679341 B.Ahvazi, K.M.Boeshans, W.Idler, U.Baxa, and P.M.Steinert (2003).
Roles of calcium ions in the activation and activity of the transglutaminase 3 enzyme.
  J Biol Chem, 278, 23834-23841.
PDB codes: 1nud 1nuf 1nug
12563291 L.Lorand, and R.M.Graham (2003).
Transglutaminases: crosslinking enzymes with pleiotropic functions.
  Nat Rev Mol Cell Biol, 4, 140-156.  
14566064 S.E.Iismaa, S.Holman, M.A.Wouters, L.Lorand, R.M.Graham, and A.Husain (2003).
Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases.
  Proc Natl Acad Sci U S A, 100, 12636-12641.  
  12742721 T.Chen, H.D.Embree, E.M.Brown, M.M.Taylor, and G.F.Payne (2003).
Enzyme-catalyzed gel formation of gelatin and chitosan: potential for in situ applications.
  Biomaterials, 24, 2831-2841.  
12485989 F.Brunner, S.Rosahl, J.Lee, J.J.Rudd, C.Geiler, S.Kauppinen, G.Rasmussen, D.Scheel, and T.Nürnberger (2002).
Pep-13, a plant defense-inducing pathogen-associated pattern from Phytophthora transglutaminases.
  EMBO J, 21, 6681-6688.  
12368090 L.Fesus, and M.Piacentini (2002).
Transglutaminase 2: an enigmatic enzyme with diverse functions.
  Trends Biochem Sci, 27, 534-539.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.